Magazine
Subscribe
Submit Press Release
Issue Archives
Virtual Issue Archives
Special Sections
NJBT E-News
About / Sign Up
Submit Press Release
Archives
NJB News Now
Sponsored Content
Industries
Accounting
Banking / Financial
Coronavirus
Economic Development
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Law
Meeting Places
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Advertising
Upcoming Opportunities
Media Kit Request
File Upload
MagHub Login
Awards
Awards for Excellence Nomination
2023 New Good Neighbor Nomination Form
About
NJB Magazine
NJBIA
Contact
Daily E-News Sign Up
Subscribe
Blog
Twitter
Facebook
Google
Linkedin
Magazine
Subscribe
Submit Press Release
Issue Archives
Virtual Issue Archives
Special Sections
NJBT E-News
About / Sign Up
Submit Press Release
Archives
NJB News Now
Sponsored Content
Industries
Accounting
Banking / Financial
Coronavirus
Economic Development
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Law
Meeting Places
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Advertising
Upcoming Opportunities
Media Kit Request
File Upload
MagHub Login
Awards
Awards for Excellence Nomination
2023 New Good Neighbor Nomination Form
About
NJB Magazine
NJBIA
Contact
Tag
Merck
Merck to Acquire Afferent Pharmaceuticals
Merck Names Sanat Chattopadhyay President of Merck Manufacturing Division
Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration
Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award
Stevens Institute of Technology Receives $251,000 Instrumentation Donation from Merck
Merck to Acquire Cubist Pharmaceuticals
Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine
Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy
FDA Approves Merck’s BELSOMRA® (suvorexant) for the Treatment of Insomnia
July Business Briefs
Merck Launches Global Patient Registry Supporting Expanded Commitment to Real-World Outcomes Research in Type 2 Diabetes
Merck to Acquire Idenix
June Business Briefs
Merck Signs Sale Agreement with Santen for Merck’s Ophthalmology Products
Bayer to Acquire Consumer Care Business of US-based Merck & Co., Inc.
« Previous
1
2
3
Articles by Industry
Accounting
Banking / Financial
Coronavirus
Diversity
Economic Development
Economy
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Labor
Law
Life Sciences
Manufacturing
Meeting Places
New Hire/Promotion
Philanthropy
Real Estate
Science & Technology
Small Business
Sponsored Content
Tourism
Workforce Development
Special Sections
Sponsored Content
NEW JERSEY BUSINESS TODAY!
Join our Daily E-News Service
Email
(Required)
First Name
(Required)
Last Name
(Required)
Company
(Required)
Comments
This field is for validation purposes and should be left unchanged.
Δ